Search - tctmd.com

Displaying 41 - 60 of 300

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: John Forrest

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Double Device Harmony for Challenging Anatomy

Presenter: Horst Sievert, Robert J. Sommer, David Meerkin

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Presenter: Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A Case of Primary in Which Sequential Transcatheter Procedures May Be Appropriate

Presenter: Omar Khalique

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A TR Case in the Presence of a Prior Tricuspid Valve Replacement

Presenter: Thomas Smith

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Aspiration of TV Endocarditis With an 8F System

Presenter: A. Pieter Kappetein, Dee Dee Wang, Yasir Akhtar, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CASE #5 New York City (Columbia)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A Case of Secondary MR With Severe Posterior Leaflet Tenting and Reduced EF

Presenter: Gilbert Tang

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Presenter: A. Pieter Kappetein, Dee Dee Wang, Chad Morreale, MD

June 22, 2018

Advertisement

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Conductor (Illustrative Cases)

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Conductor (Illustrative Cases)

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Double Device Harmony for Challenging Anatomy

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

A Case of Primary in Which Sequential Transcatheter Procedures May Be Appropriate

A TR Case in the Presence of a Prior Tricuspid Valve Replacement

Aspiration of TV Endocarditis With an 8F System

CASE #5 New York City (Columbia)

A Case of Secondary MR With Severe Posterior Leaflet Tenting and Reduced EF

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content